Indication
Respiratory cystic fibrosis
Respiratory cystic fibrosis refers to the pulmonary manifestations of cystic fibrosis, an autosomal recessive multi-organ genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene. Read more about Respiratory cystic fibrosis
9 drugs 9 manufacturers
Drugs that treat it
Common Respiratory cystic fibrosis therapies.
PULMOZYME (dornase alfa)
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
BRONCHITOL (mannitol)
BRONCHITOL (mannitol)
ACETYLCYSTEINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRespiratory cystic fibrosis refers to the pulmonary manifestations of cystic fibrosis, an autosomal recessive multi-organ genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene.
Defective or absent CFTR epithelial ion channels impair chloride and bicarbonate transport and lead to hyperabsorption of sodium and water, resulting in thick, dehydrated mucus secretions that obstruct the airways.
This progressive respiratory pathology affects pediatric and adult populations and is characterized by impaired mucociliary clearance, chronic neutrophilic airway inflammation, recurrent or persistent bacterial endobronchial infections, bronchiectasis, and progressive airflow limitation.
Over time, these pathological changes lead to structural lung destruction, episodic pulmonary exacerbations, and eventual respiratory failure, representing the primary cause of morbidity and mortality in cystic fibrosis.
- nih.gov
Respiratory cystic fibrosis refers to the pulmonary manifestations of cystic fibrosis, an autosomal recessive multi-organ genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene
- nih.gov
Respiratory cystic fibrosis refers to the pulmonary manifestations of cystic fibrosis, an autosomal recessive multi-organ genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene Over time, these pathological changes lead to structural lung destruction, episodic pulmonary exacerbations, and eventual respiratory failure, representing the primary cause of morbidity and mortality in cystic fibrosis
- medlineplus.gov
Defective or absent CFTR epithelial ion channels impair chloride and bicarbonate transport and lead to hyperabsorption of sodium and water, resulting in thick, dehydrated mucus secretions that obstruct the airways
- researchgate.net
Defective or absent CFTR epithelial ion channels impair chloride and bicarbonate transport and lead to hyperabsorption of sodium and water, resulting in thick, dehydrated mucus secretions that obstruct the airways This progressive respiratory pathology affects pediatric and adult populations and is characterized by impaired mucociliary clearance, chronic neutrophilic airway inflammation, recurrent or persistent bacterial endobronchial infections, bronchiectasis, and progressive airflow limitatio...
- medlineplus.gov
This progressive respiratory pathology affects pediatric and adult populations and is characterized by impaired mucociliary clearance, chronic neutrophilic airway inflammation, recurrent or persistent bacterial endobronchial infections, bronchiectasis, and progressive airflow limitation
Personalize your experience
Follow Respiratory cystic fibrosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.